Skip to main content

What the FDA labels say about taking them together

Riociguat and ritonavir

Riociguat's FDA label of August 13, 2026 names ritonavir in its drug interactions section; the ritonavir label PlainMeds reads does not name riociguat. The riociguat label: “… inhibitors such as azole antimycotics or HIV protease inhibitors (such as ritonavir) increase riociguat exposure and may result in hypotension.”

Check it at the source: the riociguat FDA label on DailyMed (effective August 13, 2026, Bayer HealthCare Pharmaceuticals Inc.); the ritonavir FDA label on DailyMed (effective July 23, 2026, AbbVie Inc.).

What does the riociguat label say about ritonavir?

Riociguat label, drug interactions

Strong CYP and P-gp/BCRP inhibitors: Concomitant use of riociguat with strong cytochrome CYP inhibitors and P-gp/BCRP inhibitors such as azole antimycotics (for example, ketoconazole, itraconazole) or HIV protease inhibitors (such as ritonavir) increase riociguat exposure and may result in hypotension.

Source: FDA drug label (Adempas), Bayer HealthCare Pharmaceuticals Inc., effective August 13, 2026 (SPL set 7b57509a-3d5d-41d4-8fed-1471e26372a3), via openFDA; the full label on DailyMed

What does the ritonavir label say about riociguat?

Ritonavir's label (effective July 23, 2026) does not name riociguat in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Norvir), AbbVie Inc., effective July 23, 2026 (SPL set 2849298e-de6e-47bb-8194-56e075b33fc3), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

1Riociguat generic labelers
7Ritonavir generic labelers
RiociguatRitonavir
Labeled forPulmonary arterial hypertensionHIV
Boxed warningYesYes
Pharmacy cost (NADAC)n/a$0.607 per tablet 100 mg tablet
Shortage nowNo current entryA presentation being discontinued

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?